Literature DB >> 1351142

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin.

D Green, R D Hull, R Brant, G F Pineo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1351142     DOI： 10.1016/0140-6736(92)92064-m

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

1.  Antithrombotic therapy in cancer.

Authors:  A K Kakkar; R C Williamson
Journal:  BMJ       Date:  1999-06-12

2.  Low molecular weight heparins could be important in cancer.

Authors:  S Siragusa
Journal:  BMJ       Date:  1999-09-25

3.  In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis.

Authors:  S M Smorenburg; R Vink; M te Lintelo; W Tigchelaar; A Maas; H R Büller; C J van Noorden
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

4.  Essay for the CIHR/CMAJ award: the role of low-molecular-weight heparin therapy venous thromboembolism.

Authors:  Russell Hull
Journal:  CMAJ       Date:  2011-03-21       Impact factor: 8.262

Review 5.  The hypercoagulable state of malignancy: pathogenesis and current debate.

Authors:  Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Sean T Kehoe
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

Review 6.  Anticoagulation, ferrotoxicity and the future of translational lung cancer research.

Authors:  Leo R Zacharski
Journal:  Transl Lung Cancer Res       Date:  2016-06

7.  Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest.

Authors:  Bíborka Bereczky; Réka Gilly; Erzsébet Rásó; Agnes Vágó; József Tímár; József Tóvári
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

8.  2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis.

Authors:  K Norrby
Journal:  Int J Exp Pathol       Date:  2000-06       Impact factor: 1.925

Review 9.  Epidemiology of cancer-related venous thromboembolism.

Authors:  Ted Wun; Richard H White
Journal:  Best Pract Res Clin Haematol       Date:  2009-03       Impact factor: 3.020

Review 10.  Cancer and thrombosis: mechanisms and treatment.

Authors:  Steven R Deitcher
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.